← Back to Clinical Trials
RecruitingNCT06639737

Preoperative Blood Volume Optimization Using Transthoracic Echocardiography

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionAnesthesia
SponsorUniversity Hospital, Caen
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment220
SexALL
Min Age18 Years
Max Age99 Years
Start Date2024-10-04
Completion2026-12-30
Interventions
preoperative stroke volume optimizationPost induction stroke volume optimization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Immediately following the induction of general anesthesia, arterial hypotension may occur with an incidence of about 40% in patients classified as ASA 3 or 4. Perioperative arterial hypotension is associated with increased perioperative morbidity and mortality. The increased mortality associated with perioperative arterial hypotension has been reported up to 30 and 90 days after surgery. This association appears to be both dose-dependent and time-dependent (severity and duration of arterial hypotension). EchOptimal study aims to determine whether non invasive preoperative stroke volume optimization using transthoracic echocardiography (TTE) can reduce the incidence and severity arterial hypotension following induction of general anesthesia. This is prospective, randomized, controlled, double blinded study approved by ethics comittee. The primary objective of this study is to compare the incidence of arterial hypotension (mean arterial pressure \< 65 mmHg) within the first 15 minutes following the induction of general anesthesia, between 2 groups : * standard current care (stroke volume optimized after induction of general anesthesia using oesophageal doppler) and * preopertaive stroke volume optimization using transthoracic echocardiography measument of subaortic velocity time integral.

Eligibility Criteria

Inclusion Criteria: * Patient aged 18 years or older, * Affiliated with social security, * Informed about the study and having signed the informed consent form, * Requires surgical intervention under general anesthesia, * Intermediate or high risk of cardiovascular events within 30 days, * ASA phyiscal status Classification 3 or 4 Exclusion Criteria: \- Pregnant or breastfeeding women, * Patients under guardianship, curatorship, judicial protection, or legal protection, * Minors, * Patients with contraindications to intravenous induction with Propofol and Remifentanil, * Patients not fasting at the time of surgery, * Patients with an immediate life-threatening emergency or requiring surgery without delay to ensure survival, * Patients with contraindications for placing an arterial pressure catheter in the radial artery: bilateral negative Allen's test indicating absence of ulnar collateral circulation, Raynaud's syndrome, Buerger's disease, severe dyslipidemias, * Patients with charact

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology